Small ubiquitin-like modifying protein isopeptidase assay based on poliovirus RNA polymerase activity
- PMID: 16356462
- PMCID: PMC2094218
- DOI: 10.1016/j.ab.2005.11.001
Small ubiquitin-like modifying protein isopeptidase assay based on poliovirus RNA polymerase activity
Abstract
The ubiquitin-proteasome pathway is the major nonlysosomal proteolytic system in eukaryotic cells responsible for regulating the level of many key regulatory molecules within the cells. Modification of cellular proteins by ubiquitin and ubiquitin-like proteins, such as small ubiquitin-like modifying protein (SUMO), plays an essential role in a number of biological schemes, and ubiquitin pathway enzymes have become important therapeutic targets. Ubiquitination is a dynamic reversible process; a multitude of ubiquitin ligases and deubiquitinases (DUBs) are responsible for the wide-ranging influence of this pathway as well as its selectivity. The DUB enzymes serve to maintain adequate pools of free ubiquitin and regulate the ubiquitination status of cellular proteins. Using SUMO fusions, a novel assay system, based on poliovirus RNA-dependent RNA polymerase activity, is described here. The method simplifies the isopeptidase assay and facilitates high-throughput analysis of these enzymes. The principle of the assay is the dependence of the viral polymerase on a free N terminus for activity; accordingly, the polymerase is inactive when fused at its N terminus to SUMO or any other ubiquitin-like protein. The assay is sensitive, reproducible, and adaptable to a high-throughput format for use in screens for inhibitors/activators of clinically relevant SUMO proteases and deubiquitinases.
Figures







Similar articles
-
Ubch9 conjugates SUMO but not ubiquitin.FEBS Lett. 1997 Nov 17;417(3):297-300. doi: 10.1016/s0014-5793(97)01305-7. FEBS Lett. 1997. PMID: 9409737
-
Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation.J Biol Chem. 2001 Oct 19;276(42):39060-6. doi: 10.1074/jbc.M103955200. Epub 2001 Aug 6. J Biol Chem. 2001. PMID: 11489887
-
Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli.Protein Expr Purif. 1999 Oct;17(1):128-38. doi: 10.1006/prep.1999.1100. Protein Expr Purif. 1999. PMID: 10497078
-
An in vitro FRET-based assay for the analysis of SUMO conjugation and isopeptidase cleavage.Methods Mol Biol. 2009;497:241-51. doi: 10.1007/978-1-59745-566-4_16. Methods Mol Biol. 2009. PMID: 19107422 Review.
-
Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport.Traffic. 2002 Jun;3(6):381-7. doi: 10.1034/j.1600-0854.2002.30601.x. Traffic. 2002. PMID: 12010456 Review.
Cited by
-
Hepatitis C virus nonstructural protein 5A: biochemical characterization of a novel structural class of RNA-binding proteins.J Virol. 2010 Dec;84(24):12480-91. doi: 10.1128/JVI.01319-10. Epub 2010 Oct 6. J Virol. 2010. PMID: 20926572 Free PMC article.
-
A structural feature of Dda helicase which enhances displacement of streptavidin and trp repressor from DNA.Protein Sci. 2022 Feb;31(2):407-421. doi: 10.1002/pro.4232. Epub 2021 Nov 22. Protein Sci. 2022. PMID: 34761452 Free PMC article.
-
Hijacking of multiple phospholipid biosynthetic pathways and induction of membrane biogenesis by a picornaviral 3CD protein.PLoS Pathog. 2018 May 21;14(5):e1007086. doi: 10.1371/journal.ppat.1007086. eCollection 2018 May. PLoS Pathog. 2018. PMID: 29782554 Free PMC article.
-
Interfering with nucleotide excision by the coronavirus 3'-to-5' exoribonuclease.bioRxiv [Preprint]. 2022 Aug 11:2022.08.11.503614. doi: 10.1101/2022.08.11.503614. bioRxiv. 2022. Update in: Nucleic Acids Res. 2023 Jan 11;51(1):315-336. doi: 10.1093/nar/gkac1177. PMID: 35982684 Free PMC article. Updated. Preprint.
-
Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53.Mol Cell. 2018 Feb 15;69(4):594-609.e8. doi: 10.1016/j.molcel.2018.01.023. Mol Cell. 2018. PMID: 29452639 Free PMC article.
References
-
- Ciechanover A. Ubiquitin-mediated degradation of cellular proteins: why destruction is essential for construction, and how it got from the test tube to the patient’s bed. Isr Med Assoc J. 2001;3:319–327. - PubMed
-
- Ciechanover A. The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting. Biochem Soc Trans. 2003;31:474–481. - PubMed
-
- Adams J. Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer. Curr Opin Chem Biol. 2002;6:493–500. - PubMed
-
- Melchior F. SUMO: Nonclassical ubiquitin. Annu Rev Cell Dev Biol. 2000;16:591–626. - PubMed
-
- Hochstrasser M. Evolution and function of ubiquitin-like protein–conjugation systems. Nat Cell Biol. 2000;2:E153–E157. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources